The homeodomain transcription factor Shox2 controls the development and function of the native cardiac pacemaker, the sinoatrial node (SAN). Moreover, SHOX2 mutations have been associated with cardiac arrhythmias in humans. For detailed examination of Shox2-dependent developmental mechanisms in SAN cells, we established a murine embryonic stem cell (ESC)-based model using Shox2 as a molecular tool. 
Introduction
Due to their potential to differentiate into all cell types of the three primary germ layers, embryonic stem cells (ESCs) are perfectly suited to investigate early developmental processes such as heart development (Wobus, 2001) . The investigation of cardiac cell subtype specification in differentiating ESCs provides a promising source for cell-based heart therapies including biological pacemakers.
The rhythmic beating of the heart is initiated by a population of pacemaker cells located in the sinoatrial node (SAN) (Opthof, 1988) . The development of the SAN involves a multistep differentiation process of specialized cells originating from multipotent stem cells (Christoffels et al., 2010) . Functional impairment of these cells leads to arrhythmogenic heart diseases with increased mortality risk (Choudhury et al., 2015) . The elucidation of molecular mechanisms in normal and impaired SAN development and function is therefore of crucial clinical relevance.
Previously, we and others have demonstrated that a gene regulatory network involving the homeodomain transcription factor Shox2 controls cardiac pacemaker development and specification in mouse and zebrafish (Blaschke et al., 2007; Espinoza-Lewis et al., 2009; Puskaric et al., 2010; Hoffmann et al., 2013; Ye et al., 2015) . Homozygous Shox2 deletion leads to early embryonic lethality due to developmental defects of the SAN, while heterozygous mice are viable and fertile (Blaschke et al., 2007) . In zebrafish embryos, the loss of Shox2 substantially impairs pacemaker function with severe bradycardia and irregular heartbeat (Blaschke et al., 2007; Hoffmann et al., 2013) . In line with this, we recently showed for the first time that SHOX2 mutations associate with atrial fibrillation, the most common cardiac arrhythmia in humans (Hoffmann et al., 2016) .
Shox2 activates the SAN genetic program either by direct regulation of its target Isl1, which controls cardiac pacemaker subtype identity (Hoffmann et al., 2013; Dorn et al., 2015; Vedantham et al., 2015) , or by antagonizing the transcriptional output of Nkx2.5 (Espinoza- Lewis et al., 2009 Lewis et al., , 2011 Ye et al., 2015) . Shox2-deficient mice used in the current study recapitulate this molecular pathway by diminished expression of SAN-specific genes and ectopic expression of chamberspecific genes (Blaschke et al., 2007; Puskaric et al., 2010; Hoffmann et al., 2013) . Furthermore, the SHOX2 promoter is suited for the isolation of mouse ESC-derived SAN-like cells and as lineage-specific promoter to drive the expression of a voltage-sensitive fluorescent protein in nodallike human induced pluripotent stem cell-derived cardiomyocytes Chen et al., 2017) . In addition, Shox2 overexpression during embryonic and mesenchymal stem cell differentiation strongly favours pacemaker cell specification (Ionta et al., 2015; Feng et al., 2016) . Shox2 among other embryonic transcription factors such as Tbx3, Tbx18 or Isl1 (Bakker et al., 2012; Kapoor et al., 2013; Dorn et al., 2015) , is able to direct pacemaker cell type determination. Taken together, Shox2 represents one of the major genes in the developing SAN and proper function is of crucial relevance regarding the origin of arrhythmogenic heart diseases. The elucidation of the underlying molecular mechanisms is therefore mandatory. To provide a cell-model for unravelling these mechanisms in health and disease, we established a stem cell-based cardiac differentiation model using Shox2 as a molecular tool.
Material and methods

Generation of ESC clones from Shox2-deficient mice
Superovulation was induced in viable, female Shox2 +/− C57BL/6 mice (Blaschke et al., 2007) , followed by mating. At embryonic stage E3.5 single blastocysts were collected and plated on mouse embryonic fibroblasts (MEFs). Preparation and MitomycinC (Sigma-Aldrich)-inactivation of MEFs were described earlier (Wobus et al., 2002) . Collected blastocysts were cultivated for 5 days (d) in ESC proliferation medium (Wobus et al., 2002) . Thereafter, the inner cell mass (ICM) of adherent blastocysts was mechanically picked, dissociated with trypsin/EDTA (Gibco) and replated onto MEFs in ESC proliferation medium. Cells were always cultivated at 37°C with 5% CO 2 and 95% humidity. Generated ESC clones were genotyped as previously described (Blaschke et al., 2007) .
Cultivation and differentiation of ESC clones
Generated ESC clones and the mouse ESC line R1 (Nagy et al., 1993) were cultivated and expanded on MEFs in ESC proliferation medium. In order to investigate the differentiation properties of the generated Shox2 +/+ and Shox2 −/− ESC clones, cells were differentiated according to a standard hanging drop protocol (600 cells/drop, plating of embryoid bodies (EBs) after 7d) and morphologically characterized as described earlier (Wobus et al., 2002) . Briefly, 7d EBs were plated separately in 24-well plates (one EB/well) coated with 0.1% gelatin (Sigma-Aldrich). Every second or third day, the appearance of either beating cardiomyocytes, neurons or skeletal muscle cells per EB was assessed by bright field microscopy. The appearance of the respective cell type per EB was counted, not the total number of the respective cells. The morphological analysis was limited to ectodermal and mesodermal cell derivatives, as endodermal cells are difficult to characterize by morphology.
Alkaline phosphatase (ALP) staining
Detection of ALP in generated ESC clones was carried out using an ALP-Kit (Sigma-Aldrich) as recommended by the manufacturer.
Immunofluorescence (IF) staining
IF analyses were performed with generated ESC clones and isolated beating cardiac clusters. ESC clones were stained with rabbit anti-Oct4 (1:120; abcam) and mouse anti-SSEA-1 (1:50; abcam) and visualized by incubation with anti-rabbit Alexa Fluor (AF) 488 (1:200; Molecular Probes) and anti-mouse Cy3 (1:600; Dianova). Beating cardiac clusters isolated at differentiation stage 7 + 12d (Maltsev et al., 1993) 
Quantitative real-time PCR (qPCR)
Total RNA was extracted with TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Reverse transcription was performed using the SuperScript III First-Strand Synthesis Kit (Invitrogen). qPCR was conducted using the SYBR Green Lo-Rox Fast Mix (Bioline) and the ABI 7500 Fast Real-Time PCR system (Applied Biosystems). Each sample was analyzed in duplicates and relative mRNA levels were assessed using the Relative Standard Curve Method by normalization to the reference genes succinate dehydrogenase complex subunit A (Sdha1) and hypoxanthine phosphoribosyltransferase 1 (Hprt1). Calculated values are means ± SD and presented as fold-change. Oligonucleotide sequences are given in Supplementary Table 1.
Enrichment of ESC-derived SAN-like cells
To enrich ESC-derived SAN-like cells, the R1 mouse ESC line was differentiated according to five different protocols ( Fig. 2A , Table 1 ). In brief, protocol A utilizes AG1478 (Chen et al., 2013) , whereas protocol B utilizes Suramin (Wiese et al., 2011) for the enrichment of ESC-derived SAN-like cells. Protocol C was established according to the conventional hanging drop protocol for cardiac differentiation (Wobus et al., 2002) with additional treatment by Suramin. Protocol D differs in the initial amount of cells used for EB formation, the length of suspension culture and media composition . Scavone et al. established a FACS-based protocol to isolate SAN-like cardiomyocytes during murine ESC differentiation using the surface marker CD166 (Scavone et al., 2013) . This protocol (E) was modified with regard to media composition and the predetermined number of ESCs in order to improve the efficiency of SAN cell isolation. Fluorescent activated cell sorting (FACS) in protocol E was performed by the FACS Core Facility of the Department of Medicine V in Heidelberg using a FACS Aria II SORP cell sorter. Results were evaluated by qPCR assessing the expression of Shox2 and Hcn4. Cells that had undergone treatment according to the most efficient protocol E were further investigated by comparative expression analysis using cell type-specific marker genes (Supplementary Table 1 ). Thereafter, protocol E was also applied to the Shox2 +/+ ESC clone for subsequent comparative expression analysis SAN-like cells (7 + 1d) was investigated by nCounter expression analysis at the nCounter Core Facility Heidelberg using the nCounter Dx analysis system GEN1. Detailed probe design is given in Supplementary Table 2. The workflow is described at http://www.nanostring.com/ elements/workflow. Background correction and normalization of data was performed using the nSolver Analysis Software 3.0 (NanoString Technologies). Most stable expressed genes were chosen for normalization based on the geNorm method. Log2 values are presented as ±SD.
Results
Isolation and characterization of ESCs from Shox2-deficient mice
We have established three genotypically different ESC lines (Shox2
+/− and Shox2
) by isolating pluripotent stem cells from the inner cell mass (ICM) of Shox2-deficient mouse blastocysts at stage E3.5. The ICM was separated from the blastocysts after 5d in coculture on murine embryonic fibroblasts (MEFs). After expansion, the genotype of each isolated ESC clone was determined by PCR (data not shown). In total, at least two different ESC lines per genotype have been isolated. For further characterization, one ESC clone per genotype was analyzed, respectively (data for Shox2 +/− ESC clone are not shown). Pluripotency was verified by immunofluorescent staining of the key markers Oct4 and SSEA-1. Complementing alkaline phosphatase activity analysis resulted in a distinct red staining of ESC colonies, while the surrounding MEFs remained unstained (Fig. 1A) . Our standard differentiation protocol includes embryoid body (EB) formation for 2d in hanging drops followed by 5d in suspension culture. Further differentiation was initiated by plating of EBs after 7d. Expression analysis of the pluripotency marker Pou5f1 by qPCR revealed a strong decrease in differentiated ESCs after 7 + 12d compared to undifferentiated controls (d0) for both, wildtype (WT) and knockout (KO) (Fig. 1B) . Lineage-specific marker gene qPCR analysis representing the three primary germ layers (mesoderm: Des; endoderm: Sox17; ectoderm: Nes) pointed to a spontaneous EB differentiation of all ESC clones (Fig. 1B) . Morphological evaluation calculating the percentage of EBs with specific differentiated cell types confirmed the potential of all isolated ESC clones to differentiate into cardiomyocytes, skeletal muscle and neuronal cells (Fig. 1C) . Further analysis of the differentiated ESC clones verified the expected Shox2 expression profile on transcript (Fig. 1D) and protein (Fig. 1E ) levels. No Shox2 transcript or protein was detectable in the Shox2 KO ESCs. Furthermore, the co-staining of differentiated ESCs with the sarcomere protein Titin confirmed the differentiation into cardiomyocytes (Fig. 1E) .
Differentiation of ESCs into cardiomyocytes of the SAN subtype
Various protocols for the differentiation of ESCs into specialized cardiomyocytes have been established in the past. To evaluate the most efficient enrichment of SAN-like cells in vitro, we tested five differentiation protocols ( Fig. 2A; Table 1 ) using the established and commercially available ESC line R1. We compared three previously published (A, B, D) and two specifically modified protocols (C, E) to assess the efficiency of SAN cell enrichment by marker gene expression analysis. All five protocols applied the hanging drop approach ( Fig. 2A; Table 1 ). To investigate and compare the subtype specification of SAN-like cells during differentiation of mouse ESCs, comparative expression analysis of the SAN-specific marker genes Shox2 and Hcn4 was performed by qPCR (Fig. 2B) . Most efficient enrichment of SAN-like cells was achieved with protocol E. To further evaluate this differentiation protocol on cell type specification, expression analysis of additional cell type-specific marker genes was carried out (Fig. 2C) . We could show that the SAN genes CD166, Shox2 and Hcn4 and the general cardiac cell type-specific markers Gata4 (core cardiac transcription factor), Nppa (working myocard), Actc1 (pan cardiac marker) and Ddr2 (cardiac fibroblasts) are significantly enriched in CD166
+ cells compared to unsorted controls. In contrast, a clear reduction of markers such as Sox17 (mesendoderm), Hnf6α (endoderm) and CD105 (endothelium) was demonstrated, while Tubb3 (neurons) and Acta2 (smooth muscle) showed no difference in expression levels between unsorted controls and CD166 + ESCs (Fig. 2C ).
After successful differentiation of the ESC line R1 into cardiomyocytes of the SAN subtype, protocol E was also applied to the isolated Shox2 +/+ ESCs. Expression analysis of different SAN marker genes (CD166, Shox2, Hcn4, Tbx18) by qPCR points to a highly significant enrichment of SAN-like cardiomyocytes in CD166 + cells compared to unsorted controls (Fig. 2D ). (Fig. 3) . This RNA quantification technology allows the multiplexed target measurement from only 100 ng of input with high sensitivity and specificity. We examined the expression levels of cell type specific markers (Supplementary Table  2 ) including cardiac cell subtypes, pluripotency markers and non-cardiac cell markers (e.g. neuronal markers). While no differences or no expression was detected for the non-cardiac markers (data not shown), differential expression was observed for most of the analyzed cardiac genes. In total, six of nine investigated SAN-specific genes were significantly downregulated in Shox2-deficient cells including Shox2, Hcn4, Tbx18, Tnni1, Cacna1h, Gjc1, while Cacna1g and Gjd3 showed the same trend but did not reach statistical significance (Fig. 3B ). Consistent with previously described data, the myocardial-specific gene Gja1 (Cx43) was upregulated, while Acta1 and Nppa were not significantly differently expressed (Fig. 3C) . Remarkably, the working myocard marker Nppb was significantly upregulated in Shox2 −/− SAN-like cells.
Comparative expression analysis of
To validate the differential expression identified in ESCs, we also examined Nppb expression in right atrial tissue (including the SAN) of Shox2-KO embryos compared to WT. This analysis revealed a significant upregulation of Nppb and confirmed this gene as a putative target of Shox2 in ESCs and mouse atrial tissue (Fig. 3D) . The expression of the pluripotency markers Pou5f1 and Nanog was significantly increased in the Shox2 −/− cells, suggesting a lower differentiation potential of these cells (Fig. 3E) . 
Discussion
We have previously demonstrated that a gene regulatory network involving the homeodomain transcription factor Shox2 controls the development and function of the cardiac pacemaker with a highly restricted expression pattern in the SAN (Blaschke et al., 2007; Puskaric et al., 2010; Hoffmann et al., 2013) . Shox2-deficiency is associated with impaired SAN function and increased susceptibility to atrial fibrillation (Blaschke et al., 2007; Hoffmann et al., 2016) . The molecular mechanisms underlying Shox2 function in health and disease are barely understood. This prompted us to develop a murine ESC-based cardiac differentiation model using Shox2-deficient mice, which may contribute fundamentally to the current knowledge of the intrinsic genetic program. The enrichment of an ESC-derived SAN-like cell population is a prerequisite to specifically investigate signaling pathways, mandatory for differentiation of pacemaker cells. The differentiation of ESC-derived cardiomyocytes is influenced by many parameters, including the initial number of cells per EB, media composition and specific additives (Wobus et al., 2002) . We applied and modified in total five differentiation protocols using pharmacological treatments or FACS-based selection (Wobus et al., 2002; Wiese et al., 2011; Chen et al., 2013; Scavone et al., 2013) and compared the expression levels of SAN-specific marker genes (Shox2 and Hcn4). Most efficient enrichment of SAN-like cells was observed with a previously described FACS-based differentiation protocol (Scavone et al., 2013) . The media composition and the predetermined number of ESCs were adapted to our standard differentiation protocol. For FACS analysis the surface marker CD166 was applied, as it is specifically but transiently expressed in the prospective SAN during embryonic development (Hirata et al., 2006) . FACS-based selection does not influence molecular mechanisms compared to chemical-based enrichment procedures, which is a major advantage of this protocol. However, a limitation of this methodology is the restricted amount of CD166 + cells. Only 5% of the sorted cells were CD166 + , consequently an enormous number of differentiated ESCs are required to obtain a sufficient cell number for RNA isolation and subsequent expression analysis. To overcome this challenge, nCounter technology was used for comparative expression analysis, as very low amounts of input material (100 ng) are sufficient. We observed a significant downregulation of most SAN-specific genes (6/9 targets) in the Shox2 −/− cells. This confirms the specificity of our established ESCbased cardiac differentiation model and recapitulates the data observed in the mouse model. The Shox2 −/− SAN-like cells showed highly increased transcript levels for the pluripotency markers Pou5f1 and Nanog, suggesting that Shox2-deficiency may influence the differentiation potential of ESCs and thereby explain the hypoplastic SAN phenotype observed in the KO mouse. Most remarkably, we identified Nppb (Bnp), a well-studied marker in cardiovascular disease, as a novel putative Shox2 target gene. This gene was analyzed as working myocard marker and turned out to be significantly upregulated in Shox2 −/− SAN-like cells and in right atrial tissue of Shox2-KO embryos. Interestingly, NPPB (BNP) has been previously described as direct target of SHOX2 and SHOX (a highly homologous transcription factor) in skeletal development (Marchini et al., 2007; Aza-Carmona et al., 2014) suggesting this gene as reliable target also in heart development. Recently, we could link SHOX2 mutations to atrial fibrillation, the most common arrhythmia in humans (Hoffmann et al., 2016) . In turn, elevated BNP levels and higher NPPB mRNA expression have been detected in subjects with atrial fibrillation (Tuinenburg et al., 1999; Silvet et al., 2003) suggesting that our generated ESCs have the potential to serve as an excellent in vitro model system. Taken together, we established an ESC-based cardiac differentiation model and successfully purified Shox2 +/+ and Shox2 −/− SAN-like cells. This provides a fundamental basis for the investigation of molecular pathways under physiological and pathophysiological conditions and may serve as drug testing system for evaluating novel therapeutic approaches. A-E) with R1 ESCs (n = 2) using Shox2 and Hcn4. C) Expression analysis of cell type-specific marker genes using CD166 FACS-sorted (red bars) and unsorted (grey bars) R1 ESCs (n = 2) applied to method E (Scavone et al., 2013; modified) . D) Expression analysis of CD166 and SAN marker genes using CD166 + (red bars) and unsorted (grey bars) Shox2 +/+ ESCs (n = 3) applied to method E (Scavone et al., 2013; modified) . p-values were determined by an unpaired t-test (*p b 0.05; **p b 0.01; ***p b 0.001; ****p b 0.0001). Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.scr.2017.03.018.
